These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE Martin EM; Jones SL Vet Immunol Immunopathol; 2017 Oct; 192():33-40. PubMed ID: 29042013 [TBL] [Abstract][Full Text] [Related]
5. [Research advances of prostaglandin E Liu M; Guo MN; Chen LH Sheng Li Xue Bao; 2021 Aug; 73(4):665-680. PubMed ID: 34405222 [TBL] [Abstract][Full Text] [Related]
6. Characterization of microsomal prostaglandin E synthase 1 inhibitors. Korotkova M; Jakobsson PJ Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533 [TBL] [Abstract][Full Text] [Related]
7. Microsomal prostaglandin E Zhang YY; Yao YD; Luo JF; Liu ZQ; Huang YM; Wu FC; Sun QH; Liu JX; Zhou H Pharmacol Res; 2022 Jan; 175():105977. PubMed ID: 34798265 [TBL] [Abstract][Full Text] [Related]
8. A review on mPGES-1 inhibitors: From preclinical studies to clinical applications. Bergqvist F; Morgenstern R; Jakobsson PJ Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106383. PubMed ID: 31698145 [TBL] [Abstract][Full Text] [Related]
9. The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential. Steinmetz-Späh J; Jakobsson PJ Expert Opin Ther Targets; 2023; 27(11):1115-1123. PubMed ID: 38015194 [TBL] [Abstract][Full Text] [Related]
10. Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions. Koeberle A; Laufer SA; Werz O J Med Chem; 2016 Jul; 59(13):5970-86. PubMed ID: 26791385 [TBL] [Abstract][Full Text] [Related]
11. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1). Lauro G; Strocchia M; Terracciano S; Bruno I; Fischer K; Pergola C; Werz O; Riccio R; Bifulco G Eur J Med Chem; 2014 Jun; 80():407-15. PubMed ID: 24794772 [TBL] [Abstract][Full Text] [Related]
12. Computer-Aided Drug Design of Anti-inflammatory Agents Targeting Microsomal Prostaglandin E Dos Santos Nascimento IJ; de Aquino TM; da Silva Júnior EF Curr Med Chem; 2022; 29(33):5397-5419. PubMed ID: 35301943 [TBL] [Abstract][Full Text] [Related]
13. Ellagitannins from Toda K; Ueyama M; Tanaka S; Tsukayama I; Mega T; Konoike Y; Tamenobu A; Bastian F; Akai I; Ito H; Kawakami Y; Takahashi Y; Suzuki-Yamamoto T Biosci Biotechnol Biochem; 2020 Apr; 84(4):757-763. PubMed ID: 31868102 [TBL] [Abstract][Full Text] [Related]
14. Sinomenine increases the methylation level at specific GCG site in mPGES-1 promoter to facilitate its specific inhibitory effect on mPGES-1. Luo JF; Yao YD; Cheng CS; Lio CK; Liu JX; Huang YF; He F; Xie Y; Liu L; Liu ZQ; Zhou H Biochim Biophys Acta Gene Regul Mech; 2022 Apr; 1865(3):194813. PubMed ID: 35417776 [TBL] [Abstract][Full Text] [Related]
15. Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGES-1. Akasaka H; Ruan KH Arch Biochem Biophys; 2016 Aug; 603():29-37. PubMed ID: 27177970 [TBL] [Abstract][Full Text] [Related]
16. Role of microsomal prostaglandin E synthase-1 (mPGES-1)-derived prostaglandin E2 in colon carcinogenesis. Sasaki Y; Nakatani Y; Hara S Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):42-5. PubMed ID: 26150361 [TBL] [Abstract][Full Text] [Related]
17. Novel potent benzimidazole-based microsomal prostaglandin E Ergül AG; Maz TG; Kretzer C; Olğaç A; Jordan PM; Çalışkan B; Werz O; Banoglu E Eur J Med Chem; 2022 Mar; 231():114167. PubMed ID: 35152061 [TBL] [Abstract][Full Text] [Related]
18. An Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and Diseases. Yang G; Chen L Oxid Med Cell Longev; 2016; 2016():5249086. PubMed ID: 27594972 [TBL] [Abstract][Full Text] [Related]
19. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review. Koeberle A; Werz O Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of GSK-3 reduces prostaglandin E2 production by decreasing the expression levels of COX-2 and mPGES-1 in monocyte/macrophage lineage cells. Noma T; Takahashi-Yanaga F; Arioka M; Mori Y; Sasaguri T Biochem Pharmacol; 2016 Sep; 116():120-9. PubMed ID: 27453433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]